욕창 예방 시장 : 규모, 점유율, 성장, 업계 분석, 유형별, 용도별, 지역별 인사이트, 예측(2026-2034년)

Growth Factors of pressure ulcer prevention Market

The global pressure ulcer prevention market was valued at USD 1.17 billion in 2025 and is projected to grow to USD 1.21 billion in 2026, reaching USD 1.69 billion by 2034, exhibiting a CAGR of 4.3% during the forecast period (2026-2034). North America dominated the global market with a 45.30% share in 2025, driven by advanced healthcare infrastructure, high ICU admissions, and increasing geriatric population. The U.S. market is expected to reach USD 604.9 million by 2030, reflecting strong domestic demand.

Pressure ulcers, also known as bedsores, commonly occur among hospitalized, immobile, and elderly patients. Preventive measures are increasingly preferred due to the high treatment cost burden. According to the National Institutes of Health (NIH), hospital-acquired pressure injuries (HAPI) cost between USD 3,300 million and USD 11,000 million annually, highlighting the economic importance of prevention.

COVID-19 Impact

The market experienced a temporary slowdown in 2020 due to reduced non-COVID hospital admissions and supply chain disruptions. U.S. hospital admissions dropped to 69.2% of predicted admissions in April 2020. However, longer hospital stays for COVID patients (8.4 days versus 5.2 days for non-COVID patients) increased pressure ulcer risks, driving preventive device adoption. By April 2021, hospital admissions recovered to 85.5% of predicted levels, restoring market momentum and returning it to pre-pandemic growth trends.

Latest Trends

A major trend shaping the market is the adoption of advanced technologies for prevention. Companies are introducing automated wheelchairs, alternating pressure mattresses, and smart beds that redistribute pressure. In January 2022, Invacare Corporation launched a narrower version of its AVIVA STORM RX power wheelchair designed for pressure ulcer patients.

Hospitals are also integrating motion-detection sensors that alert caregivers when patients remain immobile for extended periods. These technological advancements improve patient safety, reduce complications, and support long-term market growth.

Market Growth Drivers

1. Rising Geriatric Population & Chronic Diseases

Elderly individuals suffering from chronic conditions such as COPD, diabetes, and renal failure are at high risk of pressure ulcers due to long-term hospitalization and reduced mobility. According to America's Health Rankings Senior Report (2021), the U.S. population aged 65+ is projected to reach 85.7 million by 2050, nearly 20% of the total population. This demographic shift significantly increases demand for preventive solutions.

2. Increasing Awareness & Government Initiatives

Governments and healthcare organizations are promoting awareness campaigns such as the "Stop The Pressure" initiative in the U.K. In October 2020, Talley Group launched the 'STOP THE PRESSURE 2020' educational resource to enhance awareness among healthcare professionals and caregivers. Such initiatives are boosting product adoption globally.

Market Restraints

High product costs remain a key challenge. Advanced prevention products such as alternating air mattresses, air-fluidized beds, and wearable sensors are expensive. A 2021 NCBI cohort study estimated a wearable sensor cost of USD 39,580 per patient annually. In emerging regions such as Asia Pacific, Latin America, and the Middle East & Africa, high device costs limit widespread adoption.

Segmentation Analysis

By Product Type

The market is segmented into static support surfaces, dynamic support surfaces, dressings, positioners & protectors, and creams & others.

• Dynamic support surfaces dominated the market with 66.94% share in 2026, driven by cost-effectiveness and clinical efficiency.
• Static support surfaces held the second-largest share.
• Positioners & protectors and dressings are witnessing growing adoption due to surgical use and R&D innovations.
• Creams & others accounted for the smallest share.

By End User

• Hospitals & ambulatory surgery centers dominated with 56.20% share in 2026, supported by high ICU prevalence (16.2% ICU-acquired pressure ulcer prevalence across 90 countries).
• Long-term care & urgent care centers held the second-largest share.
• Homecare settings and clinics are expected to grow steadily due to increasing personal care demand.

Regional Insights

North America

North America generated USD 0.53 billion in 2025, maintaining dominance due to high chronic disease burden. The U.S. market is projected to reach USD 0.51 billion by 2026.

Europe

Europe held a substantial share in 2024, supported by awareness campaigns and policy initiatives. By 2026:

• U.K. market: USD 0.06 billion
• Germany market: USD 0.08 billion

Asia Pacific

Asia Pacific is projected to witness the highest CAGR. By 2026:

• Japan: USD 0.07 billion
• China: USD 0.08 billion
• India: USD 0.03 billion

Latin America & Middle East & Africa

Growth is supported by healthcare infrastructure expansion and awareness collaborations, particularly in GCC countries.

Competitive Landscape

The market is fragmented, led by Stryker, Hill-Rom Holdings, Inc., and Invacare Corporation. Strategic acquisitions strengthen market presence. In December 2021, Hill-Rom was acquired by Baxter, expanding digital health capabilities. Other key players include Arjo, Molnlycke Health Care AB, Savaria, Medline Industries, LP, Coloplast Corp., and Smith & Nephew plc.

Recent developments include product launches such as Medline's Optifoam Gentle EX dressing (2022) and Smith & Nephew's WOUND COMPASS app (2022).

Conclusion

The global pressure ulcer prevention market is poised for steady expansion from USD 1.17 billion in 2025 to USD 1.69 billion by 2034, supported by rising geriatric populations, increasing chronic disease prevalence, technological advancements, and strong government awareness initiatives. Although high device costs remain a restraint, growing emphasis on preventive healthcare and hospital quality standards will continue driving demand. North America will maintain leadership, while Asia Pacific is expected to register the fastest growth. Overall, prevention-focused strategies and innovation in support surfaces and monitoring technologies will define the market's long-term trajectory.

Segmentation By Product Type, End User, and Region

By Product Type * Static Support Surfaces

• Foam Mattresses
• Gel Overlays
• Alternating Pressure Pads
• Others
• Dynamic Support Surfaces
  • Alternating-air Mattresses
  • Low air-loss Mattresses
  • Air-fluidized or High-air-loss Mattresses
  • Others
• Dressings
• Positioners & Protectors
• Creams & Others

By End User * Hospitals & Ambulatory Surgery Centers

• Clinics
• Long Term Care & Urgent Care Centers
• Homecare Settings
• Others

By Region * North America (By Product Type, By End User, and By Country)

• U.S.
• Canada
• Europe (By Product Type, By End User, and By Country/Sub-Region)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific (By Product Type, By End User, and By Country/Sub-Region)
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Product Type, By End User, and By Country/Sub-Region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Product Type, By End User, and By Country/Sub-Region)
  • GCC
  • South Africa
  • Rest of Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Pressure Ulcers, By Key Countries, 2025
• 4.2. Geriatric Population Statistics, by Key Countries, 2025
• 4.3. Disabled Population Statistics, by Key Countries, 2025
• 4.4. New Product Launches, Key Players
• 4.5. Key Industry Developments, Mergers, Acquisitions, Partnerships, etc.
• 4.6. Technological Advancements in Pressure Ulcer Prevention Market
• 4.7. Impact of COVID-19 Pandemic on Pressure Ulcer Prevention Market

5. Global Pressure Ulcer Prevention Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product Type
  • 5.1.1. Static Support Surfaces
    • 5.1.1.1. Foam Mattresses
    • 5.1.1.2. Gel Overlays
    • 5.1.1.3. Alternating Pressure Pads
    • 5.1.1.4. Others
  • 5.1.2. Dynamic Support Surfaces
    • 5.1.2.1. Alternating-air Mattresses
    • 5.1.2.2. Low air-loss Mattresses
    • 5.1.2.3. Air-fluidized or High-air-loss Mattresses
    • 5.1.2.4. Others
  • 5.1.3. Dressings
  • 5.1.4. Positioners & Protectors
  • 5.1.5. Creams & Others
• 5.2. Market Analysis, Insights and Forecast - By End-user
  • 5.2.1. Hospitals & Ambulatory Surgery Centers
  • 5.2.2. Clinics
  • 5.2.3. Long Term Care & Urgent Care Centers
  • 5.2.4. Homecare Settings
  • 5.2.5. Others
• 5.3. Market Analysis, Insights and Forecast - By Region
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. Asia Pacific
  • 5.3.4. Latin America
  • 5.3.5. Middle East & Africa

6. North America Pressure Ulcer Prevention Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product Type
  • 6.1.1. Static Support Surfaces
    • 6.1.1.1. Foam Mattresses
    • 6.1.1.2. Gel Overlays
    • 6.1.1.3. Alternating Pressure Pads
    • 6.1.1.4. Others
  • 6.1.2. Dynamic Support Surfaces
    • 6.1.2.1. Alternating-air Mattresses
    • 6.1.2.2. Low air-loss Mattresses
    • 6.1.2.3. Air-fluidized or High-air-loss Mattresses
    • 6.1.2.4. Others
  • 6.1.3. Dressings
  • 6.1.4. Positioners & Protectors
  • 6.1.5. Creams & Others
• 6.2. Market Analysis, Insights and Forecast - By End-user
  • 6.2.1. Hospitals & Ambulatory Surgery Centers
  • 6.2.2. Clinics
  • 6.2.3. Long Term Care & Urgent Care Centers
  • 6.2.4. Homecare Settings
  • 6.2.5. Others
• 6.3. Market Analysis, Insights and Forecast - By Country
  • 6.3.1. U.S.
  • 6.3.2. Canada

7. Europe Pressure Ulcer Prevention Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product Type
  • 7.1.1. Static Support Surfaces
    • 7.1.1.1. Foam Mattresses
    • 7.1.1.2. Gel Overlays
    • 7.1.1.3. Alternating Pressure Pads
    • 7.1.1.4. Others
  • 7.1.2. Dynamic Support Surfaces
    • 7.1.2.1. Alternating-air Mattresses
    • 7.1.2.2. Low air-loss Mattresses
    • 7.1.2.3. Air-fluidized or High-air-loss Mattresses
    • 7.1.2.4. Others
  • 7.1.3. Dressings
  • 7.1.4. Positioners & Protectors
  • 7.1.5. Creams & Others
• 7.2. Market Analysis, Insights and Forecast - By End-user
  • 7.2.1. Hospitals & Ambulatory Surgery Centers
  • 7.2.2. Clinics
  • 7.2.3. Long Term Care & Urgent Care Centers
  • 7.2.4. Homecare Settings
  • 7.2.5. Others
• 7.3. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 7.3.1. Germany
  • 7.3.2. U.K.
  • 7.3.3. France
  • 7.3.4. Italy
  • 7.3.5. Spain
  • 7.3.6. Scandinavia
  • 7.3.7. Rest of Europe

8. Asia Pacific Pressure Ulcer Prevention Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product Type
  • 8.1.1. Static Support Surfaces
    • 8.1.1.1. Foam Mattresses
    • 8.1.1.2. Gel Overlays
    • 8.1.1.3. Alternating Pressure Pads
    • 8.1.1.4. Others
  • 8.1.2. Dynamic Support Surfaces
    • 8.1.2.1. Alternating-air Mattresses
    • 8.1.2.2. Low air-loss Mattresses
    • 8.1.2.3. Air-fluidized or High-air-loss Mattresses
    • 8.1.2.4. Others
  • 8.1.3. Dressings
  • 8.1.4. Positioners & Protectors
  • 8.1.5. Creams & Others
• 8.2. Market Analysis, Insights and Forecast - By End-user
  • 8.2.1. Hospitals & Ambulatory Surgery Centers
  • 8.2.2. Clinics
  • 8.2.3. Long Term Care & Urgent Care Centers
  • 8.2.4. Homecare Settings
  • 8.2.5. Others
• 8.3. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 8.3.1. China
  • 8.3.2. Japan
  • 8.3.3. India
  • 8.3.4. Australia
  • 8.3.5. Southeast Asia
  • 8.3.6. Rest of Asia Pacific

9. Latin America Pressure Ulcer Prevention Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product Type
  • 9.1.1. Static Support Surfaces
    • 9.1.1.1. Foam Mattresses
    • 9.1.1.2. Gel Overlays
    • 9.1.1.3. Alternating Pressure Pads
    • 9.1.1.4. Others
  • 9.1.2. Dynamic Support Surfaces
    • 9.1.2.1. Alternating-air Mattresses
    • 9.1.2.2. Low air-loss Mattresses
    • 9.1.2.3. Air-fluidized or High-air-loss Mattresses
    • 9.1.2.4. Others
  • 9.1.3. Dressings
  • 9.1.4. Positioners & Protectors
  • 9.1.5. Creams & Others
• 9.2. Market Analysis, Insights and Forecast - By End-user
  • 9.2.1. Hospitals & Ambulatory Surgery Centers
  • 9.2.2. Clinics
  • 9.2.3. Long Term Care & Urgent Care Centers
  • 9.2.4. Homecare Settings
  • 9.2.5. Others
• 9.3. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 9.3.1. Brazil
  • 9.3.2. Mexico
  • 9.3.3. Rest of Latin America

10. Middle East & Africa Pressure Ulcer Prevention Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product Type
  • 10.1.1. Static Support Surfaces
    • 10.1.1.1. Foam Mattresses
    • 10.1.1.2. Gel Overlays
    • 10.1.1.3. Alternating Pressure Pads
    • 10.1.1.4. Others
  • 10.1.2. Dynamic Support Surfaces
    • 10.1.2.1. Alternating-air Mattresses
    • 10.1.2.2. Low air-loss Mattresses
    • 10.1.2.3. Air-fluidized or High-air-loss Mattresses
    • 10.1.2.4. Others
  • 10.1.3. Dressings
  • 10.1.4. Positioners & Protectors
  • 10.1.5. Creams & Others
• 10.2. Market Analysis, Insights and Forecast - By End-user
  • 10.2.1. Hospitals & Ambulatory Surgery Centers
  • 10.2.2. Clinics
  • 10.2.3. Long Term Care & Urgent Care Centers
  • 10.2.4. Homecare Settings
  • 10.2.5. Others
• 10.3. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 10.3.1. GCC Countries
  • 10.3.2. South Africa
  • 10.3.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
  • 11.2.1. Agiliti Health, Inc.
    • 11.2.1.1. Overview,
    • 11.2.1.2. Product,
    • 11.2.1.3. SWOT Analysis,
    • 11.2.1.4. Recent Developments,
    • 11.2.1.5. Strategies,
    • 11.2.1.6. financials (Based on Availability)
  • 11.2.2. Arjo
    • 11.2.2.1. Overview,
    • 11.2.2.2. Product,
    • 11.2.2.3. SWOT Analysis,
    • 11.2.2.4. Recent Developments,
    • 11.2.2.5. Strategies,
    • 11.2.2.6. financials (Based on Availability)
  • 11.2.3. Savaria
    • 11.2.3.1. Overview,
    • 11.2.3.2. Product,
    • 11.2.3.3. SWOT Analysis,
    • 11.2.3.4. Recent Developments,
    • 11.2.3.5. Strategies,
    • 11.2.3.6. financials (Based on Availability)
  • 11.2.4. Medline Industries, LP
    • 11.2.4.1. Overview,
    • 11.2.4.2. Product,
    • 11.2.4.3. SWOT Analysis,
    • 11.2.4.4. Recent Developments,
    • 11.2.4.5. Strategies,
    • 11.2.4.6. financials (Based on Availability)
  • 11.2.5. Coloplast Corp.
    • 11.2.5.1. Overview,
    • 11.2.5.2. Product,
    • 11.2.5.3. SWOT Analysis,
    • 11.2.5.4. Recent Developments,
    • 11.2.5.5. Strategies,
    • 11.2.5.6. financials (Based on Availability)
  • 11.2.6. Smith & Nephew plc
    • 11.2.6.1. Overview,
    • 11.2.6.2. Product,
    • 11.2.6.3. SWOT Analysis,
    • 11.2.6.4. Recent Developments,
    • 11.2.6.5. Strategies,
    • 11.2.6.6. financials (Based on Availability)
  • 11.2.7. Stryker
    • 11.2.7.1. Overview,
    • 11.2.7.2. Product,
    • 11.2.7.3. SWOT Analysis,
    • 11.2.7.4. Recent Developments,
    • 11.2.7.5. Strategies,
    • 11.2.7.6. financials (Based on Availability)
  • 11.2.8. Molnlycke Health Care AB
    • 11.2.8.1. Overview,
    • 11.2.8.2. Product,
    • 11.2.8.3. SWOT Analysis,
    • 11.2.8.4. Recent Developments,
    • 11.2.8.5. Strategies,
    • 11.2.8.6. financials (Based on Availability)
  • 11.2.9. Hill-Rom Holdings, Inc.
    • 11.2.9.1. Overview,
    • 11.2.9.2. Product,
    • 11.2.9.3. SWOT Analysis,
    • 11.2.9.4. Recent Developments,
    • 11.2.9.5. Strategies,
    • 11.2.9.6. financials (Based on Availability)
  • 11.2.10. Invacare Corporation
    • 11.2.10.1. Overview,
    • 11.2.10.2. Product,
    • 11.2.10.3. SWOT Analysis,
    • 11.2.10.4. Recent Developments,
    • 11.2.10.5. Strategies,
    • 11.2.10.6. financials (Based on Availability)